Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

Shaare Zedek Medical Center

Status and phase: Completed; Phase 2

Conditions: ADHD

Treatments: Drug: methylphenidate

Study type: Interventional

Funder types: Other

Identifiers

NCT00364702

45/04

Details and patient eligibility

About

Using a virtual reality program in screening and treatment of ADHD.

Full description

Virtual Reality is a novel program designed to imitate a real classroom environment including various distractions. It includes a head monitor to track eye movements Children aged 10-20 years with ADHD will use the program with and without methylphenidate(1 mg/kg). Their results will be compared to a control group.

Parental consent will be obtained.

Enrollment: 40 estimated patients

Sex: All

Ages: 10 to 20 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Clinical diagnosis of ADHD-DSM4 criteria AGE 10-20 YEARS normal neurological examination IQ>80

Exclusion criteria

ABNORMAL NEUROLOGICAL STATUS

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)